Ona Therapeutics, S.L.mark2019-06-19T13:23:03+02:00
Ona Therapeutics, S.L.
Novel target to treat metastatic cancer.
Spin off from IRB Barcelona based on the research conducted by Dr. Aznar-Benitah in the field of lipid metabolism. Developing a drug targeting metastasis-initiating cells for the treatment of metastatic cancer, a clear unmet clinical need.